Prognostic value of the lymph node ratio after resection of periampullary carcinomas

HPB (Oxford). 2014 Jun;16(6):582-91. doi: 10.1111/j.1477-2574.2012.00614.x. Epub 2012 Nov 19.

Abstract

Background: Data have indicated that the lymph node ratio (LNR) may be a better prognostic indicator than lymph node status in pancreatic cancer.

Objectives: To analyse the value of the LNR in patients undergoing resection for periampullary carcinomas.

Methods: A cut off value of 0.2 was assigned to the LNR in accordance with published studies. The impact of histopathological factors including a LNR was analysed using Kaplan-Meier and Cox regression methods.

Results: In total, 551 patients undergoing a resection (January 2000 to December 2010) were analysed. The median lymph node yield was 15, and 198 (34%) patients had a LNR > 0.2. In patients with a LNR of > 0.2, the median overall survival (OS) was 18 versus 33 months in patients with an LNR < 0.2 (P < 0.001). Univariate analysis demonstrated a LNR > 0.2, T and N stage, vascular or perineural invasion, grade and resection margin status to be significantly associated with OS. On multivariate analysis, only a LNR > 0.2, vascular or perineural invasion and margin positivity remained significant. In N1 disease, a LNR was able to distinguish survival in patients with a similar lymph node burden, and correlated with more aggressive tumour pathological variables.

Conclusion: A LNR > 0.2, and not lymph note status, is an independent prognostic factor for OS indicating the LNR should be utilized in outcome stratification.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Ampulla of Vater / pathology
  • Ampulla of Vater / surgery*
  • Carcinoma / mortality
  • Carcinoma / pathology
  • Carcinoma / surgery*
  • Chi-Square Distribution
  • Common Bile Duct Neoplasms / mortality
  • Common Bile Duct Neoplasms / pathology
  • Common Bile Duct Neoplasms / surgery*
  • England
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Lymph Node Excision* / adverse effects
  • Lymph Node Excision* / mortality
  • Lymph Nodes / pathology
  • Lymph Nodes / surgery*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm, Residual
  • Ohio
  • Pancreatic Neoplasms / mortality
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / surgery*
  • Pancreaticoduodenectomy* / adverse effects
  • Pancreaticoduodenectomy* / mortality
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome